gabexate has been researched along with Angiomyolipoma in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Angiomyolipoma: A benign tumor containing vascular, adipose, and muscle elements. It occurs most often in the kidney with smooth muscle elements (angiolipoleiomyoma) in association with tuberous sclerosis. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ukai, K | 1 |
| Fuji, A | 1 |
| Nishiwaki, J | 1 |
| Yamada, T | 1 |
| Hotta, N | 1 |
| Kobayashi, Y | 1 |
| Kondo, C | 1 |
| Miyajima, K | 1 |
| Takada, T | 1 |
| Kinoshita, Y | 1 |
| Hanai, S | 1 |
1 other study available for gabexate and Angiomyolipoma
| Article | Year |
|---|---|
Giant hepatic angiomyolipoma associated with disseminated intravascular coagulation.
Topics: Aged; Angiomyolipoma; Anticoagulants; Disseminated Intravascular Coagulation; Female; Fibrinolysis; | 1997 |